GenMark Diagnostics, Inc. (GNMK) Financial Statements (2024 and earlier)

Company Profile

Business Address 5964 LA PLACE COURT
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:137,300132,79547,06653,46033,18741,360
Cash and cash equivalents57,80982,42126,26144,36024,30823,733
Short-term investments    9,100  
Other undisclosed cash, cash equivalents, and short-term investments79,49150,37420,805 8,87917,627
Receivables16,23117,86725,72116,75910,4486,756
Inventory, net of allowances, customer advances and progress billings19,57014,9279,92711,30112,5709,912
Inventory19,57014,9279,92711,30112,5709,912
Prepaid expense    1,877  
Other undisclosed current assets2,8131,8231,800 2,0712,085
Total current assets:175,914167,41284,51483,39758,27660,113
Noncurrent Assets
Operating lease, right-of-use asset8,8454,372    
Property, plant and equipment26,21019,42019,58020,41918,86318,927
Intangible assets, net (including goodwill)9891,1371,2841,4321,5801,727
Intangible assets, net (excluding goodwill)9891,1371,2841,4321,5801,727
Restricted cash and investments1,6461,646758 758758
Other noncurrent assets9861,026945825809766
Other undisclosed noncurrent assets   4,5115,4004,7664,883
Total noncurrent assets:38,67627,60127,07828,07626,77627,061
TOTAL ASSETS:214,590195,013111,592111,47385,05287,174
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,31524,03017,72912,24917,72713,739
Employee-related liabilities13,0748,6097,396 7,7205,349
Accounts payable21,24115,42110,33312,24910,0078,390
Debt 2,7411,8703,431   
Other liabilities3,6143,2453,7932,7322,0892,167
Other undisclosed current liabilities  1,8569,3351,8281,815
Total current liabilities:40,67029,14526,80924,31621,64417,721
Noncurrent Liabilities
Long-term debt and lease obligation79,65575,40666,21069,14548,72048,271
Long-term debt, excluding current maturities70,74370,18966,21069,14548,72048,271
Liabilities, other than long-term debt30828557 5562
Other liabilities30828557 5562
Operating lease, liability8,9125,217    
Other undisclosed noncurrent liabilities   5,513(69,092)6,0716,339
Total noncurrent liabilities:79,96375,69171,7805354,84654,672
Other undisclosed liabilities    74,941  
Total liabilities:120,633104,83698,58999,31076,49072,393
Equity
Equity, attributable to parent93,95790,17713,00312,1638,56214,781
Common stock776666
Additional paid in capital622,951615,995534,177526,294512,451506,949
Accumulated other comprehensive income15210061965197
Accumulated deficit(529,153)(525,925)(521,241)(514,233)(503,946)(492,271)
Total equity:93,95790,17713,00312,1638,56214,781
TOTAL LIABILITIES AND EQUITY:214,590195,013111,592111,47385,05287,174

Income Statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues42,64640,08638,74227,19620,91818,374
Cost of revenue(26,103)(24,235)(22,590)(18,079)(13,868)(11,801)
Gross profit:16,54315,85116,1529,1177,0506,573
Operating expenses(17,809)(18,544)(21,157)(17,823)(17,338)(18,483)
Operating loss:(1,266)(2,693)(5,005)(8,706)(10,288)(11,910)
Nonoperating expense(1,979)(1,928)(1,988)(1,545)(1,420)(1,353)
Interest and debt expense(2,073)(2,037)(2,091)(1,630)(1,527)(1,528)
Other undisclosed income from continuing operations before equity method investments, income taxes2,0732,0372,0911,6301,5271,528
Loss from continuing operations before income taxes:(3,245)(4,621)(6,993)(10,251)(11,708)(13,263)
Income tax expense (benefit)17(63)(15)(36)33(45)
Loss from continuing operations:(3,228)(4,684)(7,008)(10,287)(11,675)(13,308)
Loss before gain (loss) on sale of properties:(3,228)(4,684)(7,008)(10,287)(11,675)(13,308)
Net loss available to common stockholders, diluted:(3,228)(4,684)(7,008)(10,287)(11,675)(13,308)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(3,228)(4,684)(7,008)(10,287)(11,675)(13,308)
Other comprehensive income (loss)5239(35)37,108(11,721)(13,287)
Comprehensive income (loss):(3,176)(4,645)(7,043)26,821(23,396)(26,595)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (74,126)23,35026,616
Comprehensive income (loss), net of tax, attributable to parent:(3,176)(4,645)(7,043)(47,305)(46)21

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: